CH91246A - Method of preserving serum and lymph preparations. - Google Patents
Method of preserving serum and lymph preparations.Info
- Publication number
- CH91246A CH91246A CH91246DA CH91246A CH 91246 A CH91246 A CH 91246A CH 91246D A CH91246D A CH 91246DA CH 91246 A CH91246 A CH 91246A
- Authority
- CH
- Switzerland
- Prior art keywords
- sep
- lymph
- preparations
- serum
- preserving
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
EMI0001.0001
Verfahren <SEP> zum <SEP> Haltbarmachen <SEP> von <SEP> Serum- <SEP> und <SEP> Lymphepräparaten.
EMI0001.0002
Die <SEP> Konservierung <SEP> von <SEP> Heilseren <SEP> und
<tb> Lymphen <SEP> wurde <SEP> bisher <SEP> durch <SEP> Zusatz <SEP> von
<tb> Plienolen, <SEP> bezw. <SEP> CTlyzerin, <SEP> erstrebt.
<tb> F, <SEP> wurde <SEP> befunden, <SEP> daL> <SEP> dieses <SEP> Ziel <SEP> durch
<tb> Zugabe <SEP> geringer <SEP> Mengen <SEP> von <SEP> Al;ridinfarb stoffen, <SEP> wieTrvpaflavin <SEP> und <SEP> dergleichen, <SEP> besser
<tb> Lind <SEP> sicherer <SEP> -als <SEP> durch <SEP> die <SEP> bi,heribeii <SEP> Ver fahren <SEP> erreicht <SEP> wird. <SEP> Die <SEP> konservierende
<tb> bezw. <SEP> desiiifiziereiide <SEP> Kraft <SEP> der <SEP> i11;
ridiiifar1> stoffe <SEP> ist <SEP> eine <SEP> weit <SEP> höhere <SEP> als <SEP> die <SEP> der <SEP> be nannten <SEP> Siib,tanzen, <SEP> die <SEP> Wirk,anikeit <SEP> der
<tb> Seren <SEP> und <SEP> Lvmplien <SEP> wird <SEP> durch <SEP> sie <SEP> nicht
<tb> beeinträchtigt <SEP> lind <SEP> ausserdem <SEP> sind <SEP> bei <SEP> An wendung <SEP> dieser <SEP> Farbstoffe <SEP> sch;idliche <SEP> Neben wirkiingen <SEP> ausgeschlossen. <SEP> da <SEP> sie <SEP> im <SEP> Gegen satz <SEP> zii <SEP> den <SEP> Plienolen <SEP> iinf;iftig <SEP> sind. <SEP> Wie <SEP> in
<tb> airs:ye(leliiiteii <SEP> L\nter,uchun-en <SEP> fest-e,tellt
<tb> wurden <SEP> i.t. <SEP> ,iiid <SEP> :lkridiiifarb,toffe <SEP> als <SEP> pro-
EMI0001.0003
pliVlal;
tisclie <SEP> WUnddeSlnfektlonsinlttel <SEP> ausser ordentlich <SEP> wirksam, <SEP> daher <SEP> ist <SEP> ihre <SEP> Anwesen heit <SEP> in <SEP> der <SEP> Lymphe <SEP> von <SEP> grösster <SEP> Bedeutung
<tb> für <SEP> die <SEP> Verhütun- <SEP> sel:uiid;irer <SEP> Wundinfek tioiien <SEP> (In<B>)</B>pfscliiiden).
<tb> <I>Beispiel</I>
<tb> .Man <SEP> versetzt <SEP> Pockenlymphe <SEP> (Rollstoff)
<tb> mit <SEP> einer <SEP> 1L(isun- <SEP> voll <SEP> Ti-vpaflaviu.
EMI0001.0001
<SEP> method for <SEP> preservation <SEP> of <SEP> serum <SEP> and <SEP> lymph preparations.
EMI0001.0002
The <SEP> conservation <SEP> of <SEP> healing serums <SEP> and
<tb> Lymphs <SEP> became <SEP> so far <SEP> by <SEP> addition <SEP> from
<tb> Plienoles, <SEP> resp. <SEP> CTlycerine, <SEP> aimed at.
<tb> F, <SEP> <SEP> was found, <SEP> daL> <SEP> this <SEP> target <SEP> through
<tb> Addition <SEP> small <SEP> amounts <SEP> of <SEP> Al; ridine dyes, <SEP> like Trvpaflavin <SEP> and <SEP> like that, <SEP> better
<tb> Lind <SEP> safer <SEP> -than <SEP> through <SEP> the <SEP> bi, heribeii <SEP> procedure <SEP> is reached <SEP>. <SEP> The <SEP> conserving
<tb> resp. <SEP> desiiifyiide <SEP> force <SEP> of <SEP> i11;
ridiiifar1> stoffe <SEP> is <SEP> a <SEP> far <SEP> higher <SEP> than <SEP> the <SEP> of the <SEP> known <SEP> Siib, dance, <SEP> the <SEP> Really, anikeit <SEP> the
<tb> Serums <SEP> and <SEP> Lvmplien <SEP> becomes <SEP> through <SEP> they <SEP> not
<tb> affects <SEP> and <SEP> in addition <SEP> are <SEP> with <SEP> use <SEP> of these <SEP> dyes <SEP> sch; idle <SEP> side effects <SEP> are excluded. <SEP> because <SEP> they are <SEP> in the <SEP> opposite sentence <SEP> zii <SEP> the <SEP> plienoles <SEP> iinf; iftig <SEP>. <SEP> Like <SEP> in
<tb> airs: ye (leliiiteii <SEP> L \ nter, uchun-en <SEP> fix-e, tellt
<tb> were <SEP> i.t. <SEP>, iiid <SEP>: lkridiiifarb, toffe <SEP> as <SEP> pro-
EMI0001.0003
pliVlal;
tisclie <SEP> Wound control system <SEP> except properly <SEP> effective, <SEP> therefore <SEP> is <SEP> your <SEP> presence <SEP> in <SEP> the <SEP> lymph <SEP> of <SEP > greatest <SEP> importance
<tb> for <SEP> the <SEP> contraception <SEP> sel: uiid; irer <SEP> wound infections <SEP> (In <B>) </B> pfscliiiden).
<tb> <I> Example </I>
<tb> .Man <SEP> displaces <SEP> smallpox lymph <SEP> (roll material)
<tb> with <SEP> a <SEP> 1L (isun- <SEP> full <SEP> Ti-vpaflaviu.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH91246T | 1920-11-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH91246A true CH91246A (en) | 1921-10-17 |
Family
ID=4348588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH91246D CH91246A (en) | 1920-11-03 | 1920-11-03 | Method of preserving serum and lymph preparations. |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH91246A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2980586A (en) * | 1958-06-09 | 1961-04-18 | Norden Lab Inc | Method of producing swine erysipelas vaccine |
-
1920
- 1920-11-03 CH CH91246D patent/CH91246A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2980586A (en) * | 1958-06-09 | 1961-04-18 | Norden Lab Inc | Method of producing swine erysipelas vaccine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT275533B (en) | Process for the preparation of 2,3,4,5-tetrahydro-1H-3-benzazepines and their addition salts with inorganic or organic acids | |
AT287139B (en) | Process for the preparation of new, water-soluble monoazo dyes | |
CH91246A (en) | Method of preserving serum and lymph preparations. | |
GB471613A (en) | Improvements in or relating to composite articles and methods of making the same | |
AT266280B (en) | Process for the preparation of new, water-soluble 2: 1 chromium complex monoazo dyes | |
AT90273B (en) | Process for the production of long-lasting serum and lymph preparations. | |
AT251726B (en) | Process for the preparation of new, water-soluble monoazo dyes | |
AT276593B (en) | Process for the preparation of new, water-insoluble monoazo dyes | |
GB788863A (en) | Improvements relating to the staining of wood to resemble walnut | |
DE614254C (en) | Process for the production of water-insoluble azo dyes on the fiber | |
AT124383B (en) | Bottle blowing machine. | |
AT160242B (en) | Process for the preparation of androstanol- (3) -one- (17), its stereoisomers or its esters. | |
AT292869B (en) | Process for the preparation of new, water-soluble monoazo dyes | |
AT249202B (en) | Process for the preparation of new water-insoluble, sulfonic and carboxylic acid group-free disazo dyes | |
AT255654B (en) | Process for the preparation of stabilized, aqueous solutions of tricarbocyanine dyes | |
DE873117C (en) | Method of making plaster bandages | |
GB1036497A (en) | Method of setting hair | |
GB1251887A (en) | ||
GB1362041A (en) | Manufacture of a vinyl sulphonate or vinylsulphonic acid from carbyl sulphate | |
AT151319B (en) | Artificial sausage casing. | |
CH524722A (en) | Process for the production of level dyeings of equal ends with water-soluble leuco-sulfuric acid esters of vat dyes on cellulose-containing textile materials | |
AT274984B (en) | Process for the preparation of new, water-soluble monoazo dyes | |
FR2171416A1 (en) | Finishing/pre-shrinkage - of high shrinkage fabrics | |
GB431636A (en) | Improvements in laundry drying lines | |
CH176249A (en) | Process for manual machining of aluminum sheet. |